CLS Investments »

Regeneron Pharmaceuticals shares owned by CLS Investments

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by CLS Investments

Quarter filed Position value Share count Share price at filing
2012-12-31 $275k 1.6k 171.23
2012-09-30 $254k 1.7k 152.92

More positions owned by CLS Investments

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Total (IXUS)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Tr Core Us Aggbd Et (AGG)
J P Morgan Exchange Traded F Us Value Factr (JVAL)
Invesco Exch Traded Fd Tr Ii Ftse Rafi Emng (PXH)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr S&p Divid Etf (SDY)

View all positions for CLS Investments

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals